Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCasos de sarampo nos EUA até 31 de agosto?
Casos de sarampo nos EUA até 31 de agosto?
$21,423 Vol.
31 ago 2026
2.750+
Sim
2.400+
Sim
2450+
Sim
2.500+
Sim
2550+
Sim
2600+
Sim
2650+
Yes
2700+
Yes
$21,423 Vol.
2.750+
$3,369 Vol.
Sim
2.400+
$2,169 Vol.
Sim
2450+
$774 Vol.
Sim
2.500+
$1,695 Vol.
Sim
2550+
$4,813 Vol.
Sim
2600+
$4,424 Vol.
Sim
2650+
$2,609 Vol.
Yes
2700+
$1,571 Vol.
Yes
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado Aberto: Jul 31, 2026, 10:25 AM ET
Volume
$21,423Data de Término
31 ago 2026Mercado Aberto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado proposto: Sim
Sem contestação
Resultado final: Sim
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$21,423Data de Término
31 ago 2026Mercado Aberto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado proposto: Sim
Sem contestação
Resultado final: Sim
Ongoing measles transmission in the United States, driven by large outbreaks that began in 2025 and continue into 2026, has produced 2,777 confirmed cases as of August 20 according to CDC surveillance, already exceeding the full-year 2025 total of 2,289. Most cases (94%) are outbreak-associated and linked to undervaccinated communities, with the majority occurring in children and young adults. Weekly additions of 50–100 cases reflect sustained local spread rather than solely imported infections, consistent with historical patterns when MMR coverage falls below herd-immunity thresholds. CDC’s next weekly update, expected within days, and any new case reports through August 31 will determine the final cumulative total for market resolution.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions